Synergy Chc Corp ( (SNYR) ) has released its Q1 earnings. Here is a breakdown of the information Synergy Chc Corp presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Synergy CHC Corp. is a company that specializes in consumer health care and lifestyle products, with a focus on brain health supplements and wellness brands. In its first quarter of 2025, Synergy CHC Corp. reported a 30% increase in earnings per share, marking its ninth consecutive quarter of profitability. The company’s EBITDA margins expanded to 24.1%, reflecting strong operational performance and cost management. Key financial highlights include a net income increase of 51% to $876.3 thousand, despite a 13% decline in revenue to $8.2 million due to a non-recurring product sell-in the previous year. Synergy also improved its gross margin to 75.4% and reduced operating expenses by 15%. The company is preparing for international expansion and has entered debt refinancing negotiations to extend debt maturity to 2029, aiming to enhance cash flow and support growth initiatives. Looking ahead, Synergy CHC Corp. remains focused on sustainable growth and shareholder value, with plans to expand into new markets and product lines.